Sami Mahrus
- Hematology top 5%
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 4
- Molecular Biology top 5%
- Advanced biosensing and bioanalysis techniques 4
- Ubiquitin and proteasome pathways 4
- Chemical Synthesis and Analysis 3
- Oncology top 5%
- Peptidase Inhibition and Analysis 5
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 3
- Immunology top 10%
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Charles S. CraikJames A. WellsAlma L. BurlingameJennifer L. HarrisJonathan C. TrinidadJonathan A. EllmanFrancesco LeonettiBradley J. Backes
- Journals
- Cell (2 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of the American Chemical Society (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Sami Mahrus
29 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Hematology 266
- Cancer Research 337
- Molecular Biology 1.5k
- Oncology 586
- Immunology 337
Countries citing papers authored by Sami Mahrus
This map shows the geographic impact of Sami Mahrus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sami Mahrus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sami Mahrus more than expected).
Fields of papers citing papers by Sami Mahrus
This network shows the impact of papers produced by Sami Mahrus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sami Mahrus. The network helps show where Sami Mahrus may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sami Mahrus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, studybreakdown → | 2025 | 26 |
| 2 | 2025 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 13 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 1 | |
| 7 | 2018 | 14 | |
| 8 | 2016 | 59 | |
| 9 | 2015 | 5 | |
| 10 | 2012 | 119 | |
| 11 | 2010 | 160 | |
| 12 | 2008 | 372 | |
| 13 | 2008 | 41 | |
| 14 | 2005 | 132 | |
| 15 | 2004 | 79 | |
| 16 | 2003 | 65 | |
| 17 | 2002 | 42 | |
| 18 | 2001 | 20 | |
| 19 | 2000 | 276 | |
| 20 | 2000 | 450 |
About Sami Mahrus
Sami Mahrus is a scholar working on Biological Psychiatry, Cancer Research and Oncology, having authored 29 papers that have together received 2.3k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Advanced biosensing and bioanalysis techniques (4 papers), Ubiquitin and proteasome pathways (4 papers), Protease and Inhibitor Mechanisms (4 papers), Chemical Synthesis and Analysis (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Hematology (266 citations), Cancer Research (337 citations) and Molecular Biology (1.5k citations). Sami Mahrus has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Charles S. Craik, James A. Wells, Alma L. Burlingame, Jennifer L. Harris, Jonathan C. Trinidad, Jonathan A. Ellman, Francesco Leonetti, Bradley J. Backes, Andrej Săli and David T. Barkan. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.